Indeed, upon genome editing, the expression of CDK11 was dramatically decreased in vitro (>75%) followed by restored tumour-suppression protein p53 and immune-related proteins, suggesting that these multifunctional NPs based on Cs were able to reverse tumour-induced immunosuppression and prevent tumour development in vitro [63]. This evidence concerns the gene TP53 and neoplasm.